SLC28A1 and neoplasm: While both Slc28a1+/+ and Slc28a1−/− dFdC-treated mice exhibited reduced tumor growth over time, only Slc28a1+/+ mice and not Slc28a1−/−mice responded effectively to dFdC treatment.